SCHEMBL25017705

SCHEMBL25017705

c1ccc(-c2nc(-c3cccc4c3sc3ccccc34)nc(-c3cccc4oc5c(-c6nc(-c7ccccc7)c7oc8ccccc8c7n6)cccc5c34)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 11/20 0.41
▸ ALDH1A1 P00352 8/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ POLB P06746 3/20 0.41
▸ NPSR1 Q6W5P4 4/20 0.40
▸ TSHR P16473 5/20 0.39
▸ HPGD P15428 2/20 0.39
▸ LMNA P02545 5/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ KMT2A Q03164 7/20 0.38
▸ USP2 O75604 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ MEN1 O00255 6/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ GAA P10253 2/20 0.36
▸ PIK3CD O00329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22195674 1.00 MAPT (0.41) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25016498 0.96 MAPT (0.41) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25017710 0.96 MAPT (0.39) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25017366 0.96 MAPT (0.39) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25016488 0.94 MAPT (0.39) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25016528 0.94 MAPT (0.41) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL22195669 0.94 MAPT (0.41) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25016739 0.94 MAPT (0.41) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL25017696 0.92 PRKDC (0.36) MAPTALDH1A1KDM4EPOLBNPSR1
SCHEMBL22195913 0.92 PRKDC (0.36) MAPTALDH1A1KDM4EPOLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2023-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578076-B2 Heterocyclic compound and organic light emitting device using the same CYBA, SUN2, TMEM109 MAPT 1736/4885ALDH1A1 195/4885KDM4E 3083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback